The Ebola Hemmorhagic Fever (EHF) is caused by a strain of the ebola viruses. There are five ebola strains and either one may lead to the eruption of the symptoms associated with Ebola fever. When a case is reported, the only hope rests in restricting movement of people from the affected countries to others.
The signs of Ebola may start off mildly but they can quickly spiral to dangerous levels.
Signs and Symptoms of Ebola
It takes two to twenty-one days for the ebola virus symptoms to occur after infection. This is according to World Health Organization (WHO). The initial symptoms mimic the flu; fever, muscular pain, sore throat, and headaches. Thereafter, the patient may exhibit symptoms such as vomiting, a rash on the skin and diarrhea. Decreased function of the liver and kidney may also be detected in the patient. At this point, the patient will begin to experience severe symptoms such as uncomtrolled internal and external bleeding. At this point, the patients stands at a high risk of losing their lives. Studies show that 25-90 percent of the victims succumb to the symptoms.This is mainly as a result of the fluid loss experienced as soon as the symptoms begin.
Treatment of Ebola
There is neither cure nor prevention of ebola. Doctors and other medical practioners work towards controlling and treating the symptoms. Although the disease is deadly, some people are lucky enough to survive the outbreak. This is solely attributed to the strength of their own immune system. However, keeping the patient well hydrated may help them recover. Ensuring that their breathing is good will also strengthen their immune system.
At some poimt, scientists and medical experts tried blood transfusion of a survivor to a patient as a means of treatment. They believed that the antibodies of the survivor would strengthen the immune system of the patient hence fight off the disease as well.
The ZMAPP is an experimental treatment that is believed to be effective. It contains 3 monoclonol antibodies. These bind to the virus and aids the body’s immune system to clear it out. Studies have been conducted in monkeys and it has been observed that the Zmapp can indeed cure monkeys injected with lethal dosages of the ebola virus after 5 days of experiencing the symptoms. Zmapp has been approved in Africa.
Brincidofovil is an oral drug that is proved effective in preventing the virus from replicating itself. It is at its phase 3 stage which means that it is approved. It has been administered to large groups of people with positive effects.
According to WHO, one in three people survive the ebola virus. In the latest outbreak of the disease in virus in March 13, 2016, 10,000 patients survived. Some of them continue to experience side effects associated with the symptoms that they experienced while down with Ebola. Research also shows that ebola survivors may experience prolonged symptoms which may clear with time.